Drugs / Triamcinelone acetonide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01593527 | Sep 2012 | gout | Novartis Pharmaceuticals | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Triamcinelone acetonide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01593527 ↗ |
| Route | Intramuscular | “Triamcinelone acetonide 40 mg i.m.” NCT01593527 ↗ |